Review article · 2024 · Open access

Drug repurposing for cancer therapy

Ying Xia, Ming Hua Sun, Hai Huang, Weilin Jin

Signal Transduction and Targeted Therapy, 9(1), 92 · Published 18 April 2024 · DOI 10.1038/s41392-024-01808-1

Free PDFView at the publisherCite this paper

In brief

“Drug repurposing for cancer therapy” is a 2024 review article by Ying Xia and 3 co-authors, published in Signal Transduction and Targeted Therapy. OpenAlex counts 516 citations as of 15 November 2026. It is open access under a CC BY licence: the full text is free to read at Signal Transduction and Targeted Therapy.

Citations
516
Most cited in
2025 (238)
Field-weighted impact
13.28
References
507
Authors
4

Abstract

Cancer, a complex and multifactorial disease, presents a significant challenge to global health. Despite significant advances in surgical, radiotherapeutic and immunological approaches, which have improved cancer treatment outcomes, drug therapy continues to serve as a key therapeutic strategy. However, the clinical efficacy of drug therapy is often constrained by drug resistance and severe toxic side effects, and thus there remains a critical need to develop novel cancer therapeutics. One promising strategy that has received widespread attention in recent years is drug repurposing: the identification of new applications for existing, clinically approved drugs. Drug repurposing possesses several inherent advantages in the context of cancer treatment since repurposed drugs are typically cost-effective, proven to be safe, and can significantly expedite the drug development process due to their already established safety profiles. In light of this, the present review offers a comprehensive overview of the various methods employed in drug repurposing, specifically focusing on the repurposing of drugs to treat cancer. We describe the antitumor properties of candidate drugs, and discuss in detail how they target both the hallmarks of cancer in tumor cells and the surrounding tumor microenvironment. In addition, we examine the innovative strategy of integrating drug repurposing with nanotechnology to enhance topical drug delivery. We also emphasize the critical role that repurposed drugs can play when used as part of a combination therapy regimen. To conclude, we outline the challenges associated with repurposing drugs and consider the future prospects of these repurposed drugs transitioning into clinical application.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Xia, Y., Sun, M. H., Huang, H., & Jin, W. (2024). Drug repurposing for cancer therapy. Signal Transduction and Targeted Therapy, 9(1), 92. https://doi.org/10.1038/s41392-024-01808-1

MLA 9

Xia, Ying, et al. “Drug repurposing for cancer therapy.” Signal Transduction and Targeted Therapy, vol. 9, no. 1, 2024, p. 92. https://doi.org/10.1038/s41392-024-01808-1.

Chicago

Xia, Ying, Ming Hua Sun, Hai Huang, and Weilin Jin. 2024. “Drug repurposing for cancer therapy.” Signal Transduction and Targeted Therapy 9 (1): 92. https://doi.org/10.1038/s41392-024-01808-1.

Harvard

Xia, Y. et al. (2024) ‘Drug repurposing for cancer therapy’, Signal Transduction and Targeted Therapy, 9(1), p. 92. doi:10.1038/s41392-024-01808-1.

IEEE

Y. Xia, M. H. Sun, H. Huang, and W. Jin, “Drug repurposing for cancer therapy,” Signal Transduction and Targeted Therapy, vol. 9, no. 1, p. 92, 2024, doi: 10.1038/s41392-024-01808-1.

BibTeX

@article{xia2024drug,
  title     = {{Drug repurposing for cancer therapy}},
  author    = {Xia, Ying and Sun, Ming Hua and Huang, Hai and Jin, Weilin},
  journal   = {Signal Transduction and Targeted Therapy},
  year      = {2024},
  volume    = {9},
  number    = {1},
  pages     = {92},
  doi       = {10.1038/s41392-024-01808-1},
  url       = {https://doi.org/10.1038/s41392-024-01808-1}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202111
20246262
2025238238
2026215215

Its field-weighted citation impact is 13.28: it has been cited 13.28 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods

  • drug repurposing
  • cancer therapy
  • cancer hallmarks
  • tumor microenvironment
  • drug resistance
  • combination therapy
  • nanotechnology
  • topical drug delivery

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Xia, Y., Sun, M. H., Huang, H., & Jin, W. (2024). Drug repurposing for cancer therapy. Signal Transduction and Targeted Therapy, 9(1), 92. https://doi.org/10.1038/s41392-024-01808-1

How many times has this paper been cited?

516 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at Signal Transduction and Targeted Therapy.

Who wrote this paper?

Ying Xia, Ming Hua Sun, Hai Huang, Weilin Jin.

What is the DOI of this paper?

10.1038/s41392-024-01808-1. The permanent link is https://doi.org/10.1038/s41392-024-01808-1.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.